LIFEVANTAGE CORP Equity Method Investment, Other than Temporary Impairment
LIFEVANTAGE CORP (LFVN) reported Equity Method Investment, Other than Temporary Impairment of $0 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2023-08-28
- LIFEVANTAGE CORP equity method investment, other than temporary impairment for the quarter ending 2023-03-31 was $0.00.
- LIFEVANTAGE CORP equity method investment, other than temporary impairment for the quarter ending 2022-06-30 was $2.20M.
- LIFEVANTAGE CORP equity method investment, other than temporary impairment for the quarter ending 2022-03-31 was $0.00.
- LIFEVANTAGE CORP equity method investment, other than temporary impairment for fiscal 2022 was $2.20M.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 10-Q · filed 2023-05-04 | ||
| 2022-06-30 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-28 | $2.20M derived: sum of 2 quarters · filed 2023-08-28 | $2.20M 10-K · filed 2023-08-28 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |